Related Experiment Videos
Bromocriptine-induced blockade of pregnancy affects sleep patterns in rats
1Institute for Medical and Dental Engineering, Tokyo Medical and Dental University, Chiyoda-ku, Japan.
Neuroimmunomodulation
|July 1, 1996
Summary
Blocking prolactin (PRL) with bromocriptine suppressed pregnancy-related sleep increases in rats, indicating PRL
Area of Science:
- Neuroscience
- Reproductive Biology
- Sleep Research
Background:
- Pregnancy is associated with significant alterations in sleep patterns.
- Prolactin (PRL) has been hypothesized to play a role in modulating sleep during gestation.
Purpose of the Study:
- To investigate the role of prolactin (PRL) in pregnancy-associated sleep changes.
- To determine if blocking PRL release affects sleep architecture during pregnancy.
Main Methods:
- Pregnant rats were treated with bromocriptine (CB-154), a dopamine agonist that inhibits PRL release.
- Sleep-wake states were monitored using electroencephalogram (EEG) and electromyogram (EMG).
- Time-course changes in sleep were analyzed during different stages of pregnancy and post-treatment.
Main Results:
- Bromocriptine treatment led to abortion in all rats.
- CB-154 suppressed the nocturnal increases in non-rapid-eye-movement sleep (NREMS) and rapid-eye-movement sleep (REMS) associated with pregnancy.
- A significant decrease in diurnal NREMS was also observed with CB-154 treatment.
Conclusions:
- Inhibition of PRL release by bromocriptine neutralized pregnancy-associated sleep enhancements.
- These findings suggest that prolactin (PRL) is at least partially responsible for regulating sleep during pregnancy.
- PRL's role in sleep modulation during gestation is supported by these results.